Targeted delivery systems of small interfering RNA by systemic administration

被引:97
作者
Kawakami, Shigeru [1 ]
Hashida, Mitsuru [1 ]
机构
[1] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Drug Delivery Res, Sakyo Ku, Kyoto 6068501, Japan
关键词
small interfering RNA ( siRNA); RNA interference; liposomes; targeting; polymer; drug; delivery system;
D O I
10.2133/dmpk.22.142
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
RNA interference (RNAi) is induced by 21-25 nucleotide, double-stranded small interfering RNA (siRNA), which is incorporated into the RNAi-induced silencing complex (RISC) and is a guide for cleavage of the complementary target mRNA in the cytoplasm. There are many obstacles to in vivo delivery of siRNAs, such as degradation by enzymes in blood, interaction with blood components and non-specific uptake by the cells, which govern biodistribution in the body. In order to achieve the knockdown by siRNAs in vivo, many delivery systems of siRNAs based on physical and pharmaceutical approaches have been proposed. In addition, the immune responses of siRNA must be taken into account when considering the application of siRNAs to in vivo therapy. This review focuses on recent reports about delivery systems and immune responses of siRNAs.
引用
收藏
页码:142 / 151
页数:10
相关论文
共 78 条
[1]   A powerful nonviral vector for in vivo gene transfer into the adult mammalian brain: Polyethylenimine [J].
Abdallah, B ;
Hassan, A ;
Benoist, C ;
Goula, D ;
Behr, JP ;
Demeneix, BA .
HUMAN GENE THERAPY, 1996, 7 (16) :1947-1954
[2]   Tolerance for mutations and chemical modifications in a siRNA [J].
Amarzguioui, M ;
Holen, T ;
Babaie, E ;
Prydz, H .
NUCLEIC ACIDS RESEARCH, 2003, 31 (02) :589-595
[3]   Comparison of antisense oligonucleotides and siRNAs in cell culture and in vivo [J].
Bertrand, JR ;
Pottier, M ;
Vekris, A ;
Opolon, P ;
Maksimenko, A ;
Malvy, C .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 296 (04) :1000-1004
[4]   A VERSATILE VECTOR FOR GENE AND OLIGONUCLEOTIDE TRANSFER INTO CELLS IN CULTURE AND IN-VIVO - POLYETHYLENIMINE [J].
BOUSSIF, O ;
LEZOUALCH, F ;
ZANTA, MA ;
MERGNY, MD ;
SCHERMAN, D ;
DEMENEIX, B ;
BEHR, JP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (16) :7297-7301
[5]   RNA interference in mammalian cells by chemically-modified RNA [J].
Braasch, DA ;
Jensen, S ;
Liu, YH ;
Kaur, K ;
Arar, K ;
White, MA ;
Corey, DR .
BIOCHEMISTRY, 2003, 42 (26) :7967-7975
[6]   Biodistribution of phosphodiester and phosphorothioate siRNA [J].
Braasch, DA ;
Paroo, Z ;
Constantinescu, A ;
Ren, G ;
Öz, OK ;
Mason, RP ;
Corey, DR .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (05) :1139-1143
[7]   siRNA function in RNAi: A chemical modification analysis [J].
Chiu, YL ;
Rana, TM .
RNA, 2003, 9 (09) :1034-1048
[8]   Caspase-8 and caspase-3 small interfering RNA decreases ischemia/reperfusion injury to the liver in mice [J].
Contreras, JL ;
Vilatoba, M ;
Eckstein, C ;
Bilbao, G ;
Thompson, JA ;
Eckhoff, DE .
SURGERY, 2004, 136 (02) :390-400
[9]   Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells [J].
Elbashir, SM ;
Harborth, J ;
Lendeckel, W ;
Yalcin, A ;
Weber, K ;
Tuschl, T .
NATURE, 2001, 411 (6836) :494-498
[10]   Locked nucleic acid (LNA) mediated improvements in siRNA stability and functionality [J].
Elmén, J ;
Thonberg, H ;
Ljungberg, K ;
Frieden, M ;
Westergaard, M ;
Xu, YH ;
Wahren, B ;
Liang, ZC ;
Urum, H ;
Koch, T ;
Wahlestedt, C .
NUCLEIC ACIDS RESEARCH, 2005, 33 (01) :439-447